Neuroprotective effects of human telomerase reverse transcriptase on beta-amyloid fragment 25-35-treated human embryonic cortical neurons

Neural Regeneration Research

Volumn 4, Issue 6, 2009, Pages 405-412

  Kong, Lingping ^a   Wu, Lingzhi ^b   Zhang, Jie ^c   Liao, Yaping ^d   Wang, Huaqiao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b MEIZHOU HOSPITAL AFFILIATED TO SUN YAT SEN UNIVERSITY   (China)

^c GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^d BENGBU MEDICAL COLLEGE   (China)

Author keywords

Alzheimer's disease; Beta amyloid fragment 25 35; Cdk5; Cortical neuron; Human embryo; Human telomerase reverse transcriptase; p16

Indexed keywords

ADENOVIRUS VECTOR; AMYLOID BETA PROTEIN[25-35]; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY; PROTEIN P16; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NERVE CELL; NEUROPROTECTION; PROTEIN EXPRESSION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; VIRUS RECOMBINANT; WESTERN BLOTTING;

EID: 77949393714     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2009.06.001     Document Type: Article

References (31)

1. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004;430(7000):631-639.
2. Roth KA. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol. 2001;60(9): 829-838.
3. Kayed R, Head E, Thompson JL, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300(5618):486-489.
4. Lambert MP, Barlow AK, Chromy BA, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998;95(11): 6448- 6453.
5. Mattson MP, Fu W, Zhang P. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech Ageing Dev. 2001;122(7):659-671.
6. Chung HK, Cheong C, Song J, et al. Extratelomeric functions of telomerase. Curr Mol Med. 2005;5(2):233-241.
7. Sung YH, Choi YS, Cheong C, et al. The pleiotropy of telomerase against cell death. Mol Cells. 2005;19(3):303-309.
8. Fu W, Killen M, Culmsee C, et al. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J Mol Neurosci. 2000;14(1-2): 3-15.
9. Zhu H, Fu W, Mattson MP. The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J Neurochem. 2000;75(1):117-124.
10. Fu W, Lu C, Mattson MP. Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. J Neurosci. 2002;22(24):10710-10719.
11. Lee J, Sung YH, Cheong C, et al. TERT promotes cellular and organismal survival independently of telomerase activity. Oncogene. 2008;27(26):3754-3760.
12. Zhang P, Dilley C, Mattson MP. DNA damage responses in neural cells: Focus on the telomere. Neuroscience. 2007;145(4):1439-1448.
13. Ren JG, Xia HL, Tian YM, et al. Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett. 2001;488(3):133-138.
14. Huang XQ, Wang J, Liu JP, et al. hTERT extends proliferative lifespan and prevents oxidative stress-induced apoptosis in human lens epithelial cells. Invest Ophthalmol Vis Sci. 2005;46(7): 2503-2513.
15. Lu C, Fu W, Mattson MP. Telomerase protects developing neurons against DNA damage-induced cell death. Brain Res Dev Brain Res. 2001;131(1-2):167-171.
16. Ostenfeld T, Caldwell MA, Prowse KR, et al. Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol. 2000;164(1):215-226.
17. Liao YP, Zhang J, Zhou JY?et al. Construction and dentification of hTERT cDNA recombinant adenovirus expression vector. Shenjing Jiepouxue Zazhi. 2006;22(6):609-613.
18. Zhou JY, Zhou JM, Xie JW, et al. Testing the property for DNA-binding of human telomerase by the gel mobility shift assay. Zhongguo Laonianxue Zazhi. 2005;25(5):582-584.
19. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266(5193):2011-2015.
20. Morishima Y, Gotoh Y, Zieg J, et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci. 2001;21(19):7551-7560.
21. Lopes JP, Oliveira CR, Agostinho P. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloidbeta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies. Cell Mol Neurobiol. 2007;27(7): 943-957.
22. Ray SK, Schaecher KE, Shields DC, et al. Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease. Brain Res Brain Res Protoc. 2000;5(3):305-311.
23. Patrick GN, Zukerberg L, Nikolic M, et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 1999;402(6762):615-622.
24. Campiglia P, Esposito C, Scrima M, et al. Conformational stability of Abeta-(25-35) in the presence of thiazolidine derivatives. Chem Biol Drug Des. 2007;69(2):111-118.
25. Vaisid T, Barnoy S, Kosower NS. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells. Neuroscience. 2008;156(4):921-931.
26. Lee MS, Kwon YT, Li M, et al. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature. 2000;405(6784):360-364.
27. Dhariwala FA, Rajadhyaksha MS. An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol. 2008;28(3):351-369.
28. Yang DG, Liu L, Zheng XY. Cyclin-dependent kinase inhibitor p16(INK4a) and telomerase may co-modulate endothelial progenitor cells senescence. Ageing Res Rev. 2008;7(2):137-146.
29. Min LJ, Mogi M, Iwanami J, et al. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence. Cardiovasc Res. 2007;76(3):506-516.
30. Sharpless NE, Bardeesy N, Lee KH, et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. 2001;413(6851):86-91.
31. Anversa P, Kajstura J, Leri A, et al. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation. 2006;113(11): 1451-1463.